Authors:
King, J
McLeod, J
Gonsette, RE
Duquette, P
Ebers, G
Rice, G
Francis, G
Lapierre, Y
Freedman, MS
Oger, J
Paty, D
Sorensen, PS
Pelletier, J
Hommes, OR
Jongen, PJH
Sanders, EACM
Andersen, O
Wollheim-Sandberg, M
Chofflon, M
Bates, D
Barnes, D
Blumhardt, LD
Hawkins, C
Hughes, RAC
Palace, J
Newsom-Davis, JM
Young, CA
Ammoury, N
Bacchi, M
Francis, G
Galazka, A
Hyde, R
Shah, S
Citation: J. King et al., Randomized controlled trial of interferon-beta-1a in secondary progressiveMS - Clinical results, NEUROLOGY, 56(11), 2001, pp. 1496-1504
Citation: Rq. Hintzen et al., Analysis of effector CD4 (OX-40(+)) and CD8 (CD45RA(+) CD27(-)) T lymphocytes in active multiple sclerosis, ACT NEUR SC, 101(1), 2000, pp. 57-60
Authors:
Ebers, G
Lee, D
Rice, G
Lesaux, J
Kennedy, K
Sanders, EACM
Versteylen, RJ
van Andel, JD
Story, JP
de Milliano, M
O'Connor, P
Cheung, G
Houston, P
Hall, J
Comi, G
Filippi, M
Martinelli, V
Santuccio, G
Poggi, A
Gironi, M
Moiola, L
Duquette, P
Bourgouin, P
Pepin, G
Poirer, J
Bernier, G
Dubois, R
Metz, L
Diamond, RT
Bell, R
McGowan, D
Demchuk, A
Harris, E
Yeung, M
Murphy, A
Murray, TJ
Vandorpe, R
Bhan, V
Maxner, C
Weldon, P
Armstrong, L
Bouchard, JP
Grondin, P
Gosselin, F
Thibaut, M
Kirouac, L
Morin, A
Abramsky, O
Gomori, JM
Karussis, D
Karni, A
Mor, M
Freedman, MS
Avruch, L
Nelson, R
Christie, S
Rabinovitch, H
Freedman, C
Benavente, M
Pelletier, J
Levrier, O
Bensa, P
Dalesky, A
Paty, D
Li, D
Rhodes, B
Riddehough, A
Zhao, G
Wang, X
Chang, Y
Abdul-Ahad, A
Ammoury, N
Dupont, F
Francis, G
Furcha, R
Galazka, A
Hyde, R
Olson, M
Pernin, MO
Shah, S
Freedman, M
Ebers, G
Murray, J
O'Connor, P
Paty, D
Rice, G
Francis, G
Citation: G. Ebers et al., Evidence of interferon beta-1a dose response in relapsing-remitting MS - The OWIMS study, NEUROLOGY, 53(4), 1999, pp. 679-686
Authors:
Rice, GPA
Paszner, B
Oger, J
Lesaux, J
Paty, D
Ebers, G
Citation: Gpa. Rice et al., The evolution of neutralizing antibodies in multiple sclerosis patients treated with interferon beta-1b, NEUROLOGY, 52(6), 1999, pp. 1277-1279
Citation: Rq. Hintzen et al., Cerebrospinal fluid concentrations of soluble CD27 in HTLV-I associated myelopathy and multiple sclerosis, J NE NE PSY, 66(6), 1999, pp. 791-793